BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36575319)

  • 21. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
    Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
    Dorairaj V; Sulaiman SA; Abu N; Abdul Murad NA
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.
    Povero D; Eguchi A; Li H; Johnson CD; Papouchado BG; Wree A; Messer K; Feldstein AE
    PLoS One; 2014; 9(12):e113651. PubMed ID: 25470250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
    Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles.
    Hernández A; Geng Y; Sepúlveda R; Solís N; Torres J; Arab JP; Barrera F; Cabrera D; Moshage H; Arrese M
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165753. PubMed ID: 32126269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin β
    Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
    J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
    Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
    Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
    Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
    Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
    Muñoz-Hernández R; Gato S; Gil-Gómez A; Aller R; Rojas A; Morán L; Gallego J; Blázquez-López E; Gallego-Durán R; Montero-Vallejo R; García-Fernández V; Maya-Miles D; Rico MDC; Cubero FJ; Vaquero J; Ampuero J; Bañares R; Romero-Gómez M
    Liver Int; 2023 Sep; 43(9):1909-1919. PubMed ID: 37288714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
    Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
    Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic lipid accumulation induced by a high-fat diet is regulated by Nrf2 through multiple pathways.
    Qiu S; Liang Z; Wu Q; Wang M; Yang M; Chen C; Zheng H; Zhu Z; Li L; Yang G
    FASEB J; 2022 May; 36(5):e22280. PubMed ID: 35394671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.